You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Just as Novo Nordisk showed signs of a recovery, another cold shower hit investors as the drugmaker surprise prereleased its 2026 forecast late Tuesday, sending shares tumbling.